Clinical trial
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
NCT03714373
Study timeline
Study start (actual)2018-10-01Date precision: day
Registry last updated2024-04-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prader-Willi Syndromeunresolved
Interventions
Sponsors & collaborators
Soleno Therapeutics, Inc.lead sponsor
Mapped research locations
LondonUnited Kingdom3BostonMassachusetts, United States1DallasTexas, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1SeattleWashington, United States1ClevelandOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1IndianapolisIndiana, United States1AuroraColorado, United States1Salt Lake CityUtah, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03714373 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.